SCHEMBL23787693

SCHEMBL23787693

CCc1cc(-c2cc(CC)c(/N=N/c3c(S(=O)(=O)O)cc4ccc(N)cc4c3O)c(CC)c2)cc(CC)c1/N=N/c1c(S(=O)(=O)O)cc2cc(N)ccc2c1O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PHLPP2 Q6ZVD8 1/20 0.52
▸ ENPP2 Q13822 11/20 0.46
▸ CA2 P00918 1/20 0.42
▸ CA3 P07451 1/20 0.42
▸ PRMT3 O60678 1/20 0.41
▸ EP300 Q09472 1/20 0.41
▸ PRMT6 Q96LA8 1/20 0.41
▸ PRMT1 Q99873 1/20 0.41
▸ NSD2 O96028 1/20 0.39
▸ DUSP3 P51452 1/20 0.39
▸ PTPN5 P54829 1/20 0.39
▸ CASP6 P55212 1/20 0.39
▸ PTPN11 Q06124 1/20 0.39
▸ NT5E P21589 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ CD40 P25942 1/20 0.39
▸ CD40LG P29965 1/20 0.39
▸ SUMO2 P61956 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23787555 0.90 PHLPP2 (0.60) PHLPP2ENPP2CA2CA3MEN1
SCHEMBL23787554 0.87 PHLPP2 (0.53) PHLPP2ENPP2CA2CA3PRMT3
SCHEMBL23787645 0.86 ENPP2 (0.50) PHLPP2ENPP2CA2CA3PRMT3
SCHEMBL23787696 0.85 PHLPP2 (0.57) PHLPP2ENPP2CA2CA3MEN1
SCHEMBL23787591 0.84 PHLPP2 (0.51) PHLPP2ENPP2CA2CA3PRMT3
SCHEMBL23787791 0.84 PHLPP2 (0.51) PHLPP2ENPP2CA2CA3PRMT3
SCHEMBL23787739 0.84 ENPP2 (0.61) PHLPP2ENPP2CA2CA3PRMT3
SCHEMBL23787644 0.83 CYP1A2 (0.47) PHLPP2ENPP2PRMT3EP300PRMT6
SCHEMBL23787553 0.81 PHLPP2 (0.61) PHLPP2ENPP2MEN1HTTKMT2A
SCHEMBL29702399 0.80 ENPP2 (0.58) PHLPP2ENPP2CA2CA3PRMT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210275548-A1 NOVEL DNA POLYMERASE GAMMA INHIBITOR AND USES THEREOF ACIBADEM MEHMET ALI AYDINLAR UNIVERSITESI (TR) 2021-09-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210275548-A1 NOVEL DNA POLYMERASE GAMMA INHIBITOR AND USES THEREOF POLG, POLB, POLA1 PHLPP2 1195/4885ENPP2 2691/4885CA2 4630/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback